Search

everythinglearnresearchcommunity

for

Search:↓

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Roxithromycin, an antibiotic, can increase hair growth and might be used as a treatment for hair loss.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

Oral minoxidil can help regrow hair lost from antibody-drug conjugate treatment.

Etanercept improved arthritis and psoriasis but caused hair loss, which healed after switching to sulfasalazine.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

TNF-alpha inhibitors can cause various immune-related skin issues.

Biosimilars lower costs but don't significantly improve access.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

RTA 408 cream protects mice from radiation skin damage.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Targeted immunological therapies offer safer and more effective treatments for skin conditions like eczema and psoriasis.

Tofacitinib might be used to treat hair loss.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

A woman with bullous pemphigoid had an allergic reaction to azathioprine, but got better with alternative treatments.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Tofacitinib taken by mouth helps treat hair loss in children.

Bimekizumab can improve scarring alopecia in severe psoriasis.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.